Pain News and Research

Latest Pain News and Research

Cannabis extract drug may help patients with rheumatoid arthritis

The multi centre double blind, randomised, parallel group study in 58 patients assessed the efficacy, safety and tolerability of Sativex®, a whole plant medicinal cannabis extract, compared with placebo for the treatment of pain caused by Rheumatoid Arthritis. Study medication was administered by means of a spray into the mouth as an evening dose only and measures were assessed the following day.

11 Jun 2004

Kids as young as 6 who get frequent headaches may be using over-the-counter pain relievers too much

Kids as young as 6 who get frequent headaches may be using over-the-counter pain relievers far more than they should, and often without their parents' knowledge, suggests a study being presented at the 46th Annual Scientific Meeting of the American Headache Society (AHS).

11 Jun 2004

Arizona advisory on tick removal

As hotter temperatures draw Arizonans to the state’s high country, Department of Health Services Director Catherine Eden advised residents to take precautions against tick bites because some ticks carry germs that cause disease, including Rocky Mountain spotted fever.

11 Jun 2004

Enbrel therapy allowed more rheumatoid arthritis patients to achieve clinical remission

New results from TEMPO (Trial of Etanercept and Methotrexate with Radiographic Patient Outcomes) demonstrated that Enbrel® (etanercept) therapy allowed significantly more rheumatoid arthritis (RA) patients to achieve clinical remission at two years compared to patients treated with methotrexate alone.

11 Jun 2004

First robotic heart operations in the southern hemisphere

Monash University Department of Surgery staff have made history by performing the first robotic heart operations in the southern hemisphere.

11 Jun 2004

Docetaxel decreases the chance of dying by 24 percent in advanced-stage prostate cancer patients resistant to hormone therapy

Johns Hopkins Kimmel Cancer Center clinicians were among those at leading institutions that have completed a three-year international study showing that docetaxel, a drug made from yew tree needles, decreases the chance of dying by 24 percent in advanced-stage prostate cancer patients resistant to hormone therapy.

11 Jun 2004

Remicade shows improvement in both the arthritis and psoriasis associated with psoriatic arthritis

In this trial, REMICADE provided a 70 percent improvement (as measured by ACR 70) in symptoms of arthritis in nearly one-third of patients, compared with only 2 percent of patients on placebo at 24 weeks.

10 Jun 2004

Drug may benefit patients suffering deep scarring after radiation treatment

Cancer patients who suffer from a progressive, deep scarring of tissue following radiation treatment might benefit from a drug that’s FDA-approved to treat vascular disease, according to a University of Rochester study published in this month’s Journal of Clinical Oncology.

10 Jun 2004

Non-aspirin pain drugs may help men with recurrent prostate cancer

Early results from a University of North Carolina at Chapel Hill School of Medicine study may determine if drugs called Cox-2 inhibitors, a newer type of non-aspirin pain medicine now widely prescribed for arthritis symptoms, may benefit men with recurrent prostate cancer.

10 Jun 2004

Brain builds early warning detection system by working out the odds on potentially harmful experiences

An experiment conducted by Dr Ben Seymour and colleagues at the Wellcome Department of Imaging Neuroscience, University College London, revealed that volunteers couldn’t recall the details of a specific test which had resulted in them receiving a mild electric shock.

10 Jun 2004

Gemcitabine/paclitaxel combination helps breast cancer patients live longer

Breast cancer patients with advanced disease live longer when treated with a new drug, gemcitabine, in combination with paclitaxel, a traditional drug, according to results of a landmark global phase III study

9 Jun 2004

Untreated transient ischemic attacks put 21,000 Canadians at increased risk of death, stroke or heart attack

The Canadian Heart and Stroke Foundation warns that untreated transient ischemic attacks (TIAs) are putting nearly 21,000 Canadians at increased risk of death, stroke or heart attack.

9 Jun 2004

Genetic link between hormones and migraine

Director of the Genomics Research Centre Professor Lyn Griffiths and her team of researchers at Griffith University have identified a genetic link between hormones and migraine.

9 Jun 2004

Many epilepsy and multiple sclerosis patients believe marijuana is an effective treatment

Despite limited evidence of effectiveness, many epilepsy and multiple sclerosis patients believe marijuana is an effective treatment and are actively using it, according to two Canadian studies published in the June 8 issue of Neurology, the scientific journal of the American Academy of Neurology.

9 Jun 2004

Assessment of spinal cord stimulator in treatment of chronic pain

A neurosurgeon at the University of Illinois at Chicago is assessing how well an implanted electronic device that stimulates nerve fibers in the spinal cord relieves chronic pain.

7 Jun 2004

Chemotherapy regimen more effective and more toxic in Japanese patients than in American patients

A chemotherapy regimen commonly used to treat non-small cell lung cancer is both more effective and more toxic in Japanese patients than in American patients, researchers reported Saturday at the annual meeting of the American Society of Clinical Oncologists.

7 Jun 2004

Atrasentan reduces cancer risk by 20 percent in men with advanced hormone-resistant prostate cancer

Recent clinical studies led by Johns Hopkins Kimmel Cancer Center researchers have found that a drug called atrasentan reduces the risk by 20 percent that cancer will progress in men with advanced hormone-resistant prostate cancer.

7 Jun 2004

Gemcitabine may help breast cancer patients with advanced disease live longer

6 Jun 2004

Alfalfa sprouts recalled due to possible health risk

The Food and Drug Administration has been alerted that Sprouters Northwest, Inc. of Kent Washington is recalling 2, 3, and 5 lbs. institutional trays of its raw alfalfa sprouts sent to various food institutions because they may be linked to a recent increase in Salmonellosis in Oregon and Washington State.

5 Jun 2004

Drug Tarceva improves survival chance for patients with advanced lung cancer

Roche OSI Pharmaceuticals and Genentech today announced that their investigational drug Tarceva(TM) (erlotinib) achieved a significant 42.5% improvement in median survival compared to placebo in patients with advanced non-small cell lung cancer (NSCLC).

5 Jun 2004

Pain News and Research

Latest Pain News and Research

Cannabis extract drug may help patients with rheumatoid arthritis

Kids as young as 6 who get frequent headaches may be using over-the-counter pain relievers too much

Arizona advisory on tick removal

Enbrel therapy allowed more rheumatoid arthritis patients to achieve clinical remission

First robotic heart operations in the southern hemisphere

Docetaxel decreases the chance of dying by 24 percent in advanced-stage prostate cancer patients resistant to hormone therapy

Remicade shows improvement in both the arthritis and psoriasis associated with psoriatic arthritis

Drug may benefit patients suffering deep scarring after radiation treatment

Non-aspirin pain drugs may help men with recurrent prostate cancer

Brain builds early warning detection system by working out the odds on potentially harmful experiences

Gemcitabine/paclitaxel combination helps breast cancer patients live longer

Untreated transient ischemic attacks put 21,000 Canadians at increased risk of death, stroke or heart attack

Genetic link between hormones and migraine

Many epilepsy and multiple sclerosis patients believe marijuana is an effective treatment

Assessment of spinal cord stimulator in treatment of chronic pain

Chemotherapy regimen more effective and more toxic in Japanese patients than in American patients

Atrasentan reduces cancer risk by 20 percent in men with advanced hormone-resistant prostate cancer

Gemcitabine may help breast cancer patients with advanced disease live longer

Alfalfa sprouts recalled due to possible health risk

Drug Tarceva improves survival chance for patients with advanced lung cancer

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Pain News and Research

Latest Pain News and Research

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Newsletters you may be interested in